Mark J. Cantwell

1.4k citations
23 papers · 1.2k indexed · h-index 10
Topics
CAR-T cell therapy research (10 papers)Immunotherapy and Immune Responses (7 papers)Virus-based gene therapy research (6 papers)
Partner nations
United StatesJapanEgypt

In The Last Decade

Mark J. Cantwell

23 papers receiving 1.1k citations

Peers

Mark J. Cantwell
Comparison fields: 5 of 67
  • Immunology 697
  • Genetics 439
  • Oncology 425
  • Molecular Biology 397
  • Pathology and Forensic Medicine 202
Replace Alar Aints with:
Alar Aints Sweden
T J Kipps United States
Idit Sagiv-Barfi United States
Harvey A. Greisman United States
K Thielemans Belgium
Karla Plevová Czechia
Erich Piovan Italy
Massimiliano Manganini Italy
Tina Goossens Germany
Mark B. Leick United States
Mark J. Cantwell relative to Alar Aints Sweden Alar Aints's profile →
Citations per field
00.5×1.5×2.0×
Alar Aints · 1×
Citations per year

Countries citing papers authored by Mark J. Cantwell

Since Specialization
Citations

This map shows the geographic impact of Mark J. Cantwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Cantwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Cantwell more than expected).

Fields of papers citing papers by Mark J. Cantwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Cantwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Cantwell. The network helps show where Mark J. Cantwell may publish in the future.

Co-authorship network of co-authors of Mark J. Cantwell

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Cantwell. A scholar is included among the top collaborators of Mark J. Cantwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Cantwell. Mark J. Cantwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 9
3 7
4 3
5 1
6 2
7 68
8 1
9
Pharmacokinetic equivalence observed between an emulsion formulation of vinorelbine (ANX-530) and vinorelbine solution in a clinical study of patients with advanced cancer.
1
10 6
11 255
12
A novel emulsion formulation of docetaxel eliminates hypersensitivity reactions without impacting pharmacokinetics or antitumor activity
1
13
5,10-methylenetetrahydrofolate/5-fluorouracil combination therapy shows enhanced antitumor activity and lower systemic toxicity with a broad range of cytotoxic drugs
1
14 4
15 16
16 272
17 198
18 40
19 165
20 87

About Mark J. Cantwell

Mark J. Cantwell is a scholar working on Oncology, Biotechnology and Immunology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (7 papers) and Virus-based gene therapy research (6 papers). The work is most often cited by research in Genetics (439 citations), Immunology (697 citations) and Oncology (425 citations). Mark J. Cantwell has collaborated with scholars based in United States, Japan and Egypt. Frequent co-authors include Thomas J. Kipps, Charles Prussak, Laura Z. Rassenti, T J Kipps, Kinshi Kato, Shweta Sharma, William G. Wierda, Januario E. Castro, Li Tang and Desheng Lu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026